Skip to main content
Caplight Logo









CellBank Corp.

CellBank Corp.

Private
TokyoHealthcare & Life Scienceshttps://cellbank.co.jp/

Last Round

M&A

Dec 28, 2021

Company Overview

CellBank Corp. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a VC Round in May 2009.

CellBank Corp. is a biotechnology company that provides cell processing, cell storage, and institutional support services for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CellBank Corp. Comparables

Compare CellBank Corp. with similar companies based on industry and business-model similarity.

CellBank Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gaudi Clinical
80%
CellSource Co., Ltd.
79%
MEDINET Co., Ltd.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CellBank Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&ADec 28, 2021
VC RoundMay 1, 2009
VC RoundDec 1, 2005
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

CellBank Corp. Investors

Notable investors and investment history

CellBank Corp. investors
InvestorRounds
Resona Capital Co., Ltd.VC Round
DBJ CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 655% MoM, reaching 123.8K.

  • Nov 11, 2025

    Monthly visitors increased 90% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

CellBank Corp. Filings

Explore SEC and related filing metadata, where available.

CellBank Corp. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CellBank Corp.'s valuation, stock price, and market status.

Is CellBank Corp. a public or private company?

CellBank Corp. is a private company.

What is the current stock price of CellBank Corp.?

CellBank Corp. is a private company, so its shares have no public market price. Caplight tracks CellBank Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CellBank Corp. worth (valuation)?

Valuation information for CellBank Corp. is not publicly available.

Can I buy CellBank Corp. stock?

CellBank Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CellBank Corp.'s last funding round?

CellBank Corp.'s most recent funding round was M&A on December 28, 2021.

Who are the main investors in CellBank Corp.?

Key investors in CellBank Corp. include Resona Capital Co., Ltd., DBJ Capital.

Will CellBank Corp. IPO soon?

No public IPO plans have been announced for CellBank Corp..

How can I track CellBank Corp. secondary market activity?

Caplight tracks bids, offers, and trades in CellBank Corp.'s shares on secondary markets.

Firmographic Details

HeadquartersTokyo
Employee Range2
Year Founded2004
Last FundingDec 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?